Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberté Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries
نویسندگان
چکیده
Bernard Chevalier, MD; Sigmund Silber, MD; Seung-Jung Park, MD, PhD; Eulogio Garcia, MD; Gerhard Schuler, MD, PhD; Harry Suryapranata, MD, PhD; Jacques Koolen, MD, PhD; Karl E. Hauptmann, MD; William Wijns, MD, PhD; Marie-Claude Morice, MD; Didier Carrie, MD, PhD; Gerrit-Anne van Es, PhD; Hirofumi Nagai, PhD; Danny Detiege, MS; Dragica Paunovic, MD; Patrick W. Serruys, MD, PhD; for the NOBORI 1 Clinical Investigators
منابع مشابه
Clinical outcomes of patients treated with Nobori biolimus-eluting stent: Meta-analysis of randomized trials.
BACKGROUNDS The Nobori is a new-generation, biodegradable-polymer coated, biolimus-eluting stent (BES) that has recently been investigated in several randomized trials with inconsistent results. The aim of this study was to assess the efficacy and safety of Nobori BES versus other drug-eluting stents (DES) in patients treated with percutaneous coronary intervention (PCI). METHODS We undertook...
متن کاملOutcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery.
OBJECTIVES We sought to examine the efficacy of paclitaxel-eluting stent implantation in the left anterior descending coronary artery (LAD). BACKGROUND Restenosis and recurrent cardiac events after percutaneous intervention are more common for lesions in the LAD than other native coronary arteries, and often necessitate bypass surgery. Drug-eluting stents may improve the long-term prognosis o...
متن کاملInterference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses.
BACKGROUND There is evidence that endothelial coverage of drug-eluting stents might be delayed or absent, a risk factor for late thrombotic events. We studied the effects of different drug-polymer-device iterations on endothelium-dependent coronary vasomotion. Systemic markers of endothelial inflammation were correlated with coronary vasomotor changes. METHODS AND RESULTS Patients with paclit...
متن کاملRandomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus: the LIPSIA Yukon trial.
OBJECTIVES The objective of the study was to assess noninferiority of the polymer-free sirolimus-eluting Yukon Choice stent (Translumina GmbH, Hechingen, Germany) compared with the polymer-based Taxus Liberté stent (Boston Scientific, Natick, Massachusetts) with regard to the primary endpoint, in-stent late lumen loss, at 9 months in patients with diabetes mellitus. BACKGROUND The Yukon Choic...
متن کاملBiolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
BACKGROUND Third-generation biodegradable polymer drug-eluting stents might reduce the risk of stent thrombosis compared with first-generation permanent polymer drug-eluting stents. We aimed to further investigate the effects of a biodegradable polymer biolimus-eluting stent compared with a durable polymer-coated sirolimus-eluting stent in a population-based setting. METHODS This randomised, ...
متن کامل